We noted that the Inflation Reduction Act’s IRA focus on pharmaceutical manufacturers ignored a key player in the pharmaceutical supply chain the Pharmacy Benefit Manager.
In November of 2022, we predicted a fertile post-election congressional landscape for Pharmacy Benefit Manager (PBM) practice reform. Six months into the 118th Congress, we can confirm.